Wall Street Zen Upgrades LivaNova (NASDAQ:LIVN) to “Strong-Buy”

LivaNova (NASDAQ:LIVN) was upgraded by equities research analysts at Wall Street Zen from a “buy” rating to a “strong-buy” rating in a report released on Saturday.

Other equities analysts also recently issued reports about the company. Robert W. Baird set a $75.00 price target on LivaNova in a research note on Tuesday, December 16th. KeyCorp initiated coverage on LivaNova in a research report on Friday. They issued an “overweight” rating and a $81.00 target price for the company. Mizuho boosted their price target on LivaNova from $70.00 to $72.00 and gave the company an “outperform” rating in a report on Wednesday, December 17th. The Goldman Sachs Group set a $55.00 price objective on LivaNova and gave the stock a “neutral” rating in a research note on Wednesday, October 1st. Finally, Weiss Ratings reaffirmed a “sell (d+)” rating on shares of LivaNova in a report on Monday, December 15th. Six research analysts have rated the stock with a Buy rating, two have assigned a Hold rating and one has assigned a Sell rating to the stock. According to MarketBeat, LivaNova presently has an average rating of “Moderate Buy” and a consensus price target of $65.63.

LivaNova Price Performance

Shares of LIVN stock opened at $62.82 on Friday. The firm has a fifty day moving average of $57.31 and a two-hundred day moving average of $52.32. The firm has a market cap of $3.43 billion, a P/E ratio of -15.70 and a beta of 1.02. LivaNova has a 1-year low of $32.48 and a 1-year high of $65.57. The company has a debt-to-equity ratio of 0.30, a current ratio of 1.33 and a quick ratio of 1.12.

Institutional Inflows and Outflows

Institutional investors have recently added to or reduced their stakes in the stock. GAMMA Investing LLC raised its holdings in LivaNova by 182.5% during the 2nd quarter. GAMMA Investing LLC now owns 630 shares of the company’s stock worth $28,000 after purchasing an additional 407 shares during the last quarter. State of Wyoming bought a new position in shares of LivaNova in the 2nd quarter valued at about $31,000. EverSource Wealth Advisors LLC grew its position in shares of LivaNova by 998.4% during the 2nd quarter. EverSource Wealth Advisors LLC now owns 703 shares of the company’s stock worth $32,000 after buying an additional 639 shares during the period. Quarry LP bought a new stake in shares of LivaNova during the third quarter worth approximately $36,000. Finally, UMB Bank n.a. raised its stake in shares of LivaNova by 63.0% during the third quarter. UMB Bank n.a. now owns 792 shares of the company’s stock worth $41,000 after buying an additional 306 shares during the last quarter. 97.64% of the stock is currently owned by institutional investors.

LivaNova Company Profile

LivaNova plc is a global medical technology company that develops and manufactures products and therapies for the cardiac surgery and neuromodulation markets. Headquartered in London, United Kingdom, and Houston, Texas, LivaNova serves hospitals, clinics and healthcare providers in more than 100 countries. The company’s primary focus lies in advancing patient care through innovations in heart–lung bypass, cardiac preservation, circulatory support and neurostimulation therapies.

The Cardiac Surgery business unit offers a comprehensive portfolio of products used in cardiopulmonary bypass procedures, including oxygenators, heart–lung machines, arterial filters, cannulae and sutureless heart valves.